Drugs and Devices

FDA requires lower recommended doses for drugs containing zolpidem

On Jan. 10, 2012, the U.S. Food and Drug Administration (FDA) announced it is requiring the manufacturers of Ambien, Ambien CR, Edluar and Zolpimist, sleep drugs that contain the active ingredient zolpidem, to lower current recommended doses. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares